Northrop Grumman Corporation

“Northrop Grumman owns sole-source monopolies on two legs of the US nuclear triad and critical national security space programs — a franchise with 20+ years of visible, government-guaranteed revenue that no competitor can replicate. The near-term investment case is clouded by repeated fixed-price EAC charges on B-21 and Sentinel that have reset earnings expectations and impaired management credibility, but these are execution frictions, not structural business impairments. FCF has tripled since 2022 and is on a clear upward trajectory. At ~17x earnings and ~24x FCF, the valuation is fair for a regulated defense prime with these structural characteristics, but offers limited margin of safety until the fixed-price development overhangs are resolved. This is a business to own at the right price — that price is modestly below today's levels.”